CBD treatment significantly reduced IDO and cGAS expression, correlating with decreased proinflammatory cytokines, including TNF-ฮฑ, IL-1ฮฒ, and IFN-ฮณ. These findings support CBD as a potential monotherapy or adjunctive treatment for AD by targeting distinct neuroinflammatory pathways.
3 Key Findings: Cannabis Alzheimer’s Treatment Study 2025
Groundbreaking 2025 study shows cannabis Alzheimer’s treatment with low-dose THC-CBD improves cognitive scores in 26-week clinical trial.
5 Essential Breakthroughs in Cannabis Neuromodulation
5 Essential Breakthroughs in Cannabis Neuromodulation Imagine a world where a simple plant could revolutionize the way we treat some of the most challenging health issues, from anxiety and depression to Alzheimer's...